NCT02545088

Brief Summary

The overall purpose of this project is to establish the added value of training with the Hybrid Assistive Limb (HAL) exoskeleton system as part of regular rehabilitation intervention programs after stroke. The main specific aims are: (i) to compare potential effects on functioning and disability of gait and mobility training long-term after stroke by comparing A) HAL-training combined with conventional rehabilitation interventions to B) conventional rehabilitation interventions without HAL and to C) no intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Oct 2015

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2015

Completed
16 days until next milestone

First Posted

Study publicly available on registry

September 9, 2015

Completed
22 days until next milestone

Study Start

First participant enrolled

October 1, 2015

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
Last Updated

December 19, 2020

Status Verified

December 1, 2020

Enrollment Period

3.9 years

First QC Date

August 24, 2015

Last Update Submit

December 17, 2020

Conditions

Keywords

RehabilitationRobotics

Outcome Measures

Primary Outcomes (1)

  • Change in 6 min walk test

    walking ability and endurance

    Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention

Secondary Outcomes (28)

  • Fugl Meyer Scale for lower extremities

    Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention

  • Modified Ashworth Scale

    Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention

  • Spasticity measured with Neuroflexor foot module

    Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention

  • Berg Balance Scale

    Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention

  • 10 meters walk test

    Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention

  • +23 more secondary outcomes

Study Arms (3)

Study group Hybrid Assistive Limb (HAL)

EXPERIMENTAL
Device: Hybrid Assistive Limb (HAL)

1st control group

ACTIVE COMPARATOR
Other: 1st control group

2nd control group

ACTIVE COMPARATOR
Other: 2nd control group

Interventions

Intensive gait training with Hybrid Assistive Limb (HAL) is performed 1 session/day, 3 days/week for 6 weeks and each session will not exceed 60 min of effective walking time with HAL. In addition, each session will include conventional gait training that will not exceed 30 min effective training time.

Study group Hybrid Assistive Limb (HAL)

Conventional gait training performed 1 session/day, 3 days/week for 6 weeks that will not exceed 1h 30 min effective training time.

1st control group

The 2nd control group will not receive an intervention.

2nd control group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years since stroke onset
  • Able to walk but not independently, i.e. need of manual support or close supervision due to lower extremity paresis, FAC score 2-3 or FAC 4 combined with gait speed \<0.8m/s according to 10 meter walk test, which corresponds to limitations in community ambulation (Bowden et al 2008)
  • Ability to understand training instructions as well as written and oral study information and to express informed consent or by proxy
  • Body size compatible with the HAL suit.

You may not qualify if:

  • Contracture restricting gait movements at any lower limb joint
  • Cardiovascular or other somatic condition incompatible with intensive gait training
  • Severe, contagious infections (e.g. Methicillin Resistant Staphylococcus Aureus (MRSA) or Extended Spectrum Beta Lactamase bacteria).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Rehabilitation Medicine, Danderyd Hospital

Danderyd, Stockholm County, 18288, Sweden

Location

Related Publications (4)

  • Nilsson A, Vreede KS, Haglund V, Kawamoto H, Sankai Y, Borg J. Gait training early after stroke with a new exoskeleton--the hybrid assistive limb: a study of safety and feasibility. J Neuroeng Rehabil. 2014 Jun 2;11:92. doi: 10.1186/1743-0003-11-92.

    PMID: 24890413BACKGROUND
  • Wall A, Borg J, Palmcrantz S. Clinical application of the Hybrid Assistive Limb (HAL) for gait training-a systematic review. Front Syst Neurosci. 2015 Mar 25;9:48. doi: 10.3389/fnsys.2015.00048. eCollection 2015.

    PMID: 25859191BACKGROUND
  • Bergqvist M, Moller MC, Bjorklund M, Borg J, Palmcrantz S. The impact of visuospatial and executive function on activity performance and outcome after robotic or conventional gait training, long-term after stroke-as part of a randomized controlled trial. PLoS One. 2023 Mar 9;18(3):e0281212. doi: 10.1371/journal.pone.0281212. eCollection 2023.

  • Palmcrantz S, Wall A, Vreede KS, Lindberg P, Danielsson A, Sunnerhagen KS, Hager CK, Borg J. Impact of Intensive Gait Training With and Without Electromechanical Assistance in the Chronic Phase After Stroke-A Multi-Arm Randomized Controlled Trial With a 6 and 12 Months Follow Up. Front Neurosci. 2021 Apr 22;15:660726. doi: 10.3389/fnins.2021.660726. eCollection 2021.

MeSH Terms

Conditions

StrokeMobility LimitationParesis

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurologic Manifestations

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, Reg physiotherapist

Study Record Dates

First Submitted

August 24, 2015

First Posted

September 9, 2015

Study Start

October 1, 2015

Primary Completion

September 1, 2019

Study Completion

October 1, 2019

Last Updated

December 19, 2020

Record last verified: 2020-12

Locations